Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) EPS (Basic) (2022 - 2025)

Historic EPS (Basic) for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to -$0.29.

  • PAVmed's EPS (Basic) changed N/A to -$0.29 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.25, marking a year-over-year change of. This contributed to the annual value of $3.35 for FY2024, which is 13654.72% up from last year.
  • As of Q3 2025, PAVmed's EPS (Basic) stood at -$0.29.
  • PAVmed's 5-year EPS (Basic) high stood at $1.28 for Q1 2025, and its period low was -$14.25 during Q4 2022.
  • In the last 4 years, PAVmed's EPS (Basic) had a median value of -$0.96 in 2024 and averaged -$2.02.
  • In the last 5 years, PAVmed's EPS (Basic) tumbled by 129000.0% in 2023 and then soared by 14885.5% in 2025.
  • Quarter analysis of 4 years shows PAVmed's EPS (Basic) stood at -$14.25 in 2022, then soared by 84.57% to -$2.2 in 2023, then skyrocketed by 92.46% to -$0.17 in 2024, then crashed by 74.87% to -$0.29 in 2025.
  • Its EPS (Basic) stands at -$0.29 for Q3 2025, versus -$0.74 for Q2 2025 and $1.28 for Q1 2025.